In patient education, what should be communicated before starting NMES?

• A. Purpose, sensation expectations, how to adjust intensity, safety considerations, consent, and how to report discomfort or adverse effects.
• B. Only the device manual matters.
• C. Skip consent and proceed.
• D. Focus only on the duration of treatment.

Answer: (A)

Before starting NMES, it’s essential to educate the patient on why the treatment is being used, what sensations to expect, how to adjust the intensity, safety considerations, consent, and how to report discomfort or adverse effects. This upfront education supports informed participation and helps prevent problems.

Knowing the purpose clarifies what the therapy aims to achieve (such as muscle re-education or strengthening) and sets realistic expectations. Explaining expected sensations—like a mild tingling or comfortable muscle contraction—versus warning signs of excessive stimulation helps the patient recognize what is normal and what requires pause or adjustment. Teaching how to adjust intensity safely—starting low, ramping up gradually, and stopping if pain occurs—protects the skin and underlying tissues and ensures tolerable, effective contractions. Safety considerations cover contraindications, skin integrity, correct electrode placement, device settings, and the need for supervision, reducing risks of burns, shocks, or interference with other conditions or devices. Obtaining consent respects patient autonomy and builds trust, making it more likely they will follow the plan. Finally, instructing how to report discomfort or adverse effects—pain, burning, persistent redness, dizziness, or device malfunction—enables timely intervention and ensures ongoing safety and effectiveness.

Omitting any of these elements can leave the patient ill-informed, at risk, or unwilling to continue, which is why this comprehensive approach is the best practice.